ID   DMD_RAT                 Reviewed;        3677 AA.
AC   P11530; F1M705;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   09-DEC-2015, sequence version 2.
DT   02-OCT-2024, entry version 151.
DE   RecName: Full=Dystrophin;
GN   Name=Dmd;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 766-794, AND TISSUE SPECIFICITY.
RX   PubMed=3340214; DOI=10.1038/331635a0;
RA   Nudel U., Robzyk K., Yaffe D.;
RT   "Expression of the putative Duchenne muscular dystrophy gene in
RT   differentiated myogenic cell cultures and in the brain.";
RL   Nature 331:635-638(1988).
RN   [3]
RP   INTERACTION WITH DTNB.
RX   PubMed=10545507; DOI=10.1083/jcb.147.3.645;
RA   Blake D.J., Hawkes R., Benson M.A., Beesley P.W.;
RT   "Different dystrophin-like complexes are expressed in neurons and glia.";
RL   J. Cell Biol. 147:645-658(1999).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3615 AND SER-3616, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-
CC       actin. Ligand for dystroglycan. Component of the dystrophin-associated
CC       glycoprotein complex which accumulates at the neuromuscular junction
CC       (NMJ) and at a variety of synapses in the peripheral and central
CC       nervous systems and has a structural function in stabilizing the
CC       sarcolemma. Also implicated in signaling events and synaptic
CC       transmission. {ECO:0000250|UniProtKB:P11531}.
CC   -!- SUBUNIT: Interacts with SYNM (By similarity). Interacts with the
CC       syntrophins SNTG1 and SNTG2. Interacts with KRT19. Component of the
CC       dystrophin-associated glycoprotein complex which is composed of three
CC       subcomplexes: a cytoplasmic complex comprised of DMD (or UTRN), DTNA
CC       and a number of syntrophins, such as SNTB1, SNTB2, SNTG1 and SNTG2, the
CC       transmembrane dystroglycan complex, and the sarcoglycan-sarcospan
CC       complex. Interacts with DAG1 (betaDAG1) with DMD; the interaction is
CC       inhibited by phosphorylation on the PPXY motif of DAG1 (By similarity).
CC       Interacts with SYNM; SNTA1 and SNTB1. Interacts with CMYA5. Directly
CC       interacts with ANK2 and ANK3; these interactions do not interfere with
CC       betaDAG1-binding and are necessary for proper localization in muscle
CC       cells. Identified in a dystroglycan complex that contains at least PRX,
CC       DRP2, UTRN, DMD and DAG1 (By similarity). Interacts with DTNB
CC       (PubMed:10545507). Interacts with PGM5; the interaction is direct (By
CC       similarity). Interacts with NOS1; localizes NOS1 to sarcolemma in
CC       muscle cells (By similarity). {ECO:0000250|UniProtKB:P11531,
CC       ECO:0000250|UniProtKB:P11532, ECO:0000269|PubMed:10545507}.
CC   -!- INTERACTION:
CC       P11530; Q63279: Krt19; NbExp=3; IntAct=EBI-706166, EBI-876985;
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:P11531}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P11531}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P11531}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P11531}. Postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:P11531}. Note=In muscle cells, sarcolemma
CC       localization requires the presence of ANK2, while localization to
CC       costameres requires the presence of ANK3. Localizes to neuromuscular
CC       junctions (NMJs). In adult muscle, NMJ localization depends upon ANK2
CC       presence, but not in newborn animals. {ECO:0000250|UniProtKB:P11531}.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in skeletal muscle and weak
CC       expression observed in newborn brain which increases in adult brain.
CC       {ECO:0000269|PubMed:3340214}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07073532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC097383; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC111223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112800; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113761; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125680; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125768; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131219; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136037; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X07000; CAA30057.1; -; Genomic_DNA.
DR   PIR; S01614; S01614.
DR   RefSeq; XP_017457399.1; XM_017601910.1.
DR   SMR; P11530; -.
DR   CORUM; P11530; -.
DR   IntAct; P11530; 11.
DR   STRING; 10116.ENSRNOP00000029969; -.
DR   GlyGen; P11530; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P11530; -.
DR   PhosphoSitePlus; P11530; -.
DR   jPOST; P11530; -.
DR   PaxDb; 10116-ENSRNOP00000029969; -.
DR   Ensembl; ENSRNOT00000035692.7; ENSRNOP00000029969.6; ENSRNOG00000046366.3.
DR   AGR; RGD:2507; -.
DR   RGD; 2507; Dmd.
DR   eggNOG; KOG4286; Eukaryota.
DR   GeneTree; ENSGT00940000154342; -.
DR   InParanoid; P11530; -.
DR   OMA; XVATTYP; -.
DR   OrthoDB; 2880153at2759; -.
DR   Reactome; R-RNO-390522; Striated Muscle Contraction.
DR   PRO; PR:P11530; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000046366; Expressed in quadriceps femoris and 18 other cell types or tissues.
DR   ExpressionAtlas; P11530; baseline and differential.
DR   GO; GO:0097449; C:astrocyte projection; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; ISO:RGD.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0030055; C:cell-substrate junction; ISO:RGD.
DR   GO; GO:0043034; C:costamere; ISO:RGD.
DR   GO; GO:0016010; C:dystrophin-associated glycoprotein complex; IDA:RGD.
DR   GO; GO:0030175; C:filopodium; ISO:RGD.
DR   GO; GO:0031527; C:filopodium membrane; ISO:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; IDA:RGD.
DR   GO; GO:0099617; C:matrix side of mitochondrial inner membrane; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
DR   GO; GO:0030016; C:myofibril; IDA:RGD.
DR   GO; GO:0005883; C:neurofilament; IDA:RGD.
DR   GO; GO:0044306; C:neuron projection terminus; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0099572; C:postsynaptic specialization; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0005840; C:ribosome; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; IDA:RGD.
DR   GO; GO:0002162; F:dystroglycan binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; IPI:RGD.
DR   GO; GO:0005521; F:lamin binding; IPI:RGD.
DR   GO; GO:0017022; F:myosin binding; ISO:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0008307; F:structural constituent of muscle; ISO:RGD.
DR   GO; GO:0017166; F:vinculin binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0060348; P:bone development; ISO:RGD.
DR   GO; GO:0086001; P:cardiac muscle cell action potential; ISO:RGD.
DR   GO; GO:0060048; P:cardiac muscle contraction; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0061448; P:connective tissue development; ISO:RGD.
DR   GO; GO:0008340; P:determination of adult lifespan; ISO:RGD.
DR   GO; GO:0008065; P:establishment of blood-nerve barrier; ISO:RGD.
DR   GO; GO:0060857; P:establishment of glial blood-brain barrier; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0060173; P:limb development; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; ISO:RGD.
DR   GO; GO:0055001; P:muscle cell development; ISO:RGD.
DR   GO; GO:0042692; P:muscle cell differentiation; IEP:RGD.
DR   GO; GO:0007517; P:muscle organ development; ISO:RGD.
DR   GO; GO:0014904; P:myotube cell development; ISO:RGD.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IMP:RGD.
DR   GO; GO:1902083; P:negative regulation of peptidyl-cysteine S-nitrosylation; ISO:RGD.
DR   GO; GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; IBA:GO_Central.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:RGD.
DR   GO; GO:0051647; P:nucleus localization; ISO:RGD.
DR   GO; GO:0021629; P:olfactory nerve structural organization; ISO:RGD.
DR   GO; GO:0043043; P:peptide biosynthetic process; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IMP:BHF-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISO:RGD.
DR   GO; GO:1903409; P:reactive oxygen species biosynthetic process; ISO:RGD.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISO:RGD.
DR   GO; GO:0090287; P:regulation of cellular response to growth factor stimulus; IMP:BHF-UCL.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0002027; P:regulation of heart rate; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0090257; P:regulation of muscle system process; IBA:GO_Central.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISO:RGD.
DR   GO; GO:0014819; P:regulation of skeletal muscle contraction; ISO:RGD.
DR   GO; GO:0014809; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; ISO:RGD.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IEP:RGD.
DR   GO; GO:0035994; P:response to muscle stretch; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEP:RGD.
DR   GO; GO:0055002; P:striated muscle cell development; ISO:RGD.
DR   GO; GO:0006941; P:striated muscle contraction; ISO:RGD.
DR   GO; GO:0099536; P:synaptic signaling; IBA:GO_Central.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISO:RGD.
DR   GO; GO:0090659; P:walking behavior; ISO:RGD.
DR   CDD; cd21231; CH_DMD_rpt1; 1.
DR   CDD; cd21233; CH_DMD_rpt2; 1.
DR   CDD; cd16246; EFh_DMD; 1.
DR   CDD; cd00176; SPEC; 11.
DR   CDD; cd00201; WW; 1.
DR   CDD; cd02334; ZZ_dystrophin; 1.
DR   Gene3D; 1.20.58.60; -; 16.
DR   Gene3D; 2.20.70.10; -; 1.
DR   Gene3D; 3.30.60.90; -; 1.
DR   Gene3D; 1.10.418.10; Calponin-like domain; 2.
DR   Gene3D; 1.10.238.10; EF-hand; 2.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH_dom.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035436; Dystrophin/utrophin.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR015153; EF-hand_dom_typ1.
DR   InterPro; IPR015154; EF-hand_dom_typ2.
DR   InterPro; IPR050774; KCMF1/Dystrophin.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   InterPro; IPR000433; Znf_ZZ.
DR   InterPro; IPR043145; Znf_ZZ_sf.
DR   PANTHER; PTHR12268:SF25; DYSTROPHIN; 1.
DR   PANTHER; PTHR12268; E3 UBIQUITIN-PROTEIN LIGASE KCMF1; 1.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF09068; EF-hand_2; 1.
DR   Pfam; PF09069; EF-hand_3; 1.
DR   Pfam; PF00435; Spectrin; 17.
DR   Pfam; PF00397; WW; 1.
DR   Pfam; PF00569; ZZ; 1.
DR   PIRSF; PIRSF002341; Dystrophin/utrophin; 1.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00150; SPEC; 23.
DR   SMART; SM00456; WW; 1.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF47576; Calponin-homology domain, CH-domain; 1.
DR   SUPFAM; SSF47473; EF-hand; 2.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF46966; Spectrin repeat; 15.
DR   SUPFAM; SSF51045; WW domain; 1.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS01159; WW_DOMAIN_1; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 1.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Calcium; Cell membrane; Cytoplasm; Cytoskeleton; Membrane;
KW   Metal-binding; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Repeat; Synapse; Zinc; Zinc-finger.
FT   CHAIN           1..3677
FT                   /note="Dystrophin"
FT                   /id="PRO_0000076077"
FT   DOMAIN          15..119
FT                   /note="Calponin-homology (CH) 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          134..240
FT                   /note="Calponin-homology (CH) 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REPEAT          342..447
FT                   /note="Spectrin 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          451..557
FT                   /note="Spectrin 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          560..668
FT                   /note="Spectrin 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          728..828
FT                   /note="Spectrin 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          831..935
FT                   /note="Spectrin 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          944..1046
FT                   /note="Spectrin 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1049..1154
FT                   /note="Spectrin 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1163..1264
FT                   /note="Spectrin 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1268..1464
FT                   /note="Spectrin 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1469..1569
FT                   /note="Spectrin 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1573..1676
FT                   /note="Spectrin 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1680..1777
FT                   /note="Spectrin 12"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1779..1875
FT                   /note="Spectrin 13"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1878..1980
FT                   /note="Spectrin 14"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2001..2098
FT                   /note="Spectrin 15"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2106..2209
FT                   /note="Spectrin 16"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2215..2316
FT                   /note="Spectrin 17"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2317..2415
FT                   /note="Spectrin 18"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2465..2569
FT                   /note="Spectrin 19"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2576..2678
FT                   /note="Spectrin 20"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2682..2786
FT                   /note="Spectrin 21"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2800..2922
FT                   /note="Spectrin 22"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2927..3032
FT                   /note="Spectrin 23"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          3047..3080
FT                   /note="WW"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   ZN_FING         3300..3356
FT                   /note="ZZ-type; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   REGION          1..240
FT                   /note="Actin-binding"
FT   REGION          63..72
FT                   /note="ANK2- and ANK-3 binding"
FT                   /evidence="ECO:0000250"
FT   REGION          1416..1914
FT                   /note="Interaction with SYNM"
FT                   /evidence="ECO:0000250"
FT   REGION          3050..3400
FT                   /note="Interaction with SYNM"
FT                   /evidence="ECO:0000250"
FT   REGION          3458..3510
FT                   /note="Binds to SNTB1"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
FT   REGION          3520..3546
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3595..3677
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        3595..3664
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         3305
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         3308
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         3329
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         3332
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   MOD_RES         3475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
FT   MOD_RES         3482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
FT   MOD_RES         3492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
FT   MOD_RES         3604
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
FT   MOD_RES         3605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
FT   MOD_RES         3609
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
FT   MOD_RES         3615
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         3616
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         3658
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11532"
SQ   SEQUENCE   3677 AA;  425828 MW;  50526FA367B87FAB CRC64;
     MLWWEEVEDC YEREDVQKKT FTKWINAQFS KFGKQHIDNL FSDLQDGKRL LDLLEGLTGQ
     KLPKEKGSTR VHALNNVNKA LQVLQKNNVD LVNIGSTDIV DGNHKLTLGL IWNIILHWQV
     KNVMKTIMAG LQQTNSEKIL LSWVRESTRN YPQVNVLNFT SSWSDGLALN ALIHSHRPDL
     FDWNSVVSQQ SATQRLEHAF NIAKCQLGIE KLLDPEDVAT TYPDKKSILM YITSLFQVLP
     QQVSIEAIRE VEMLPRPSKV TREEHFQLHH QMHYSQQITV SLAQGYEQTS SSPKPRFKSY
     AFTQAAYVAT SDSSQSPYPS QHLEAPGSKS FGSSLIETEV NLDSYQTALE EVLSWLLSAE
     DTLRAQGEIS KDVEEVKEQF HAHEGFMMDL TSHQGLVGNV LQLGSRLVGK GKLTEDEETE
     VQEQMNLLNS RWECLRVASM EKQSNLHKVL MDLQNQKLKE LDDWLTKTEE RTKKMEEEPL
     GPDLEDLKCQ VQQHKVLQED LEQEQVRVNS LTHMVVVVDE SSGDHATAAL EEQLKVLGDR
     WANICKWTED RWILLQDILL KWQRFTEEQC LFSKWLSEKE DAMKNIQTSG FEDQNEMVSS
     LQNISALKID LEKKKQSMEK LSSLNQDLLS ALKNKSVTQK MEMWMENFAQ RWDNLTQKLE
     KSSAQISQAV TTTQPSLTQT TVMETVTMVT TREQIMVKHA QEELPPPPPQ KKRQITVDSE
     IRKRLDVDIT ELHSWITRSE AVLQSSEFAV YRKEGNISDL KEKVNAIARE KAEKFRKLQD
     ASRSAQALVE QMVNEGVNAE SIRQASEQLN SRWTEFCQLL SERVNWLEYQ NNIITFYNQL
     QQLEQMTTTA ENLLKTQPTT LSEPTAIKSQ LKICKDEVNR LSALQPQIER LKIQSLTLKE
     KGQGPMFLDA DFVAFTNHFN YVFDGVRARE KELQTIFDTL PPMRYQETMS SIRTWIQQSE
     NKLSIPHLSV TEYEIMEERL GKLQALQSSL KEQQNGFNYL NATVKEIAKK APSEISQKYQ
     SEFEEVEGRW KKLSTQLVEH CQKLEEHMNK LRKFQNHKKT LQKWMAEVDV FLKEEWPALG
     DAEILKKQLK QCRLLVGDIQ TIQPSLNSVN EGGQKIKSEA EFEFASRLEK ELKELNTQWD
     HICRQVYTRK EALKAGLDKT VSLQKDLSEM HEWMTQAEEE YLERDFEYKT PDELQTAVEE
     MKRAKEEALQ KEAKVKLLTE TVNSVISQAP PAAQEALKKE LETLTTNYQW LCTRLNGKCK
     TLEEVWACWH ELLSYLEKAN KWLNEVELKL KATENVPAGA EEITEVLESL ENLMHHSEEN
     PNQIRLLAQT LTDGGVMDEL INEELETFNS RWRELHEEAV RKQKLLEQSI QSAQEIEKSL
     HLIQESLEFI DKQLAAYIAD KVDAAQMPQE AQKIQSDLTS HEISLEEMKK HNQGKDANQR
     VLSQIDVAQK KLQDVSIKFR LFQKPANFEQ RLEESKMILD EVKMHLPALE TKSVEQEVVQ
     SQLSHCVNLY KSLSEVKSEV EMVIKTGRQI VQKKQTENPK ELDERVTALK LHYNELGAKV
     TERKQQLEKC LKLSRKMRKE MNVLTEWLAA TDTELTKRSA VEGMPSNLDS EVAWGKATQK
     EIEKQKAHLK SVTELGDSLK TVLGKKETLV EDKLTLLNSN WIAVTSRVEE WLNLLLEYQK
     HMESFDQNVE HITKWIIHTD ELLDESEKRK PQQKEDILKR LKAEMNDIRP KVDATRDQAA
     KLMANRGDYC RKIVEPQISE LNRRFAAISH RIKTGKASIP LKELEQFNSD IQKLLEPLEA
     EIQQGVNLKE EDFNKDMSED NEGTVNELLQ RGDNLQQRIT DERKREEIKL KQQLLQTKHN
     ALKDLRSQRR KKALEISHQW YQYKSQADDL LKCLDEIEKK LASLPEPRDE RKIKEIDREL
     QKKKEELNAV RRQAESLSEN GAAMAVEPTQ IQLSKRWREI ESNFAQFRRL NFAQIHTLHE
     ETMVVTTEDM PLDVSYVPST YLTEISHILQ ALSEVEQLLN APELNAKDFE DLFKQEESLK
     NIKENLQQIS GRIDVIHKKK TAALQSATPM ERVKLQEAVS QMDFHWEKLN RMYKERQGRF
     DRSVEKWRHF HYDMKVFNQW LNDVEQFFKK TQNPENWEHA KYKWYLKELQ DGIGQRQAVV
     RTLNATGEEI IQQSSKTDAN ILQEKLGSLS LRWHEVCKEL AERRKRVEEQ KNVFSEFQRD
     LNEFVSWLEE ADNIATTPPG DEEQLKEKLE QVKLLTEELP LRQGILKQLN ETGGAVLVSA
     PIRPEEQDKL EKKLKQTNLQ WIKVSRALPE KQGELEVHIK DFRQFEEQLD HLLLWLSPIR
     NQLEIYNQPS QPGPFDLKET EVTVQAKQPD VERLLSKGQH LYKEKPSTQP VKRKLEDLRS
     EWEAVNHLLW ELRTKQPDRA PGLSTTGASA SQTVTVVTQP VDTKETVISK LEMPSSLLLE
     VPALADFNRA WTELTDWLSL LDRVIKSQRV MVGDLEDINE MIIKQKATLQ DLEQRRPQLE
     ELITAAQNLK NKTSNQEART IITDRIERIQ IQWDEVQEQL QNRRQQLNEM LKDSTQWLEA
     KEEAEQVIGQ ARGKLDSWKE GPHTMDAIQK KITETKQLAK DLRQRQINVD VANDLALKLL
     RDYSADDTRK VHMITENINT SWGNILKRVS EREAALEETQ RLLQQFPLDL EKFLAWITEA
     ETTANVLQDA SRKEKLLEDS RGVRELMKPW QDLQGEIEAH TDIYHNLDEN GQKILRSLEG
     SDEAPLLQRR LDNMNFKWSE LRKKSLNIRS HLEVSSDQWK RLHLSLQELL VWLQLKDDEL
     SRQAPIGGDF PAVQKQNDVH RAFKRELKTK EPVIMSTLET VRIFLTEQPL EGLEKLYQEP
     RELPPEERAQ NVTRLLRKQA EEVNTEWDKL NLHSADWQRK IDEALERLQE LQEAADELDL
     KLRQAEVIKG SWQPVGDLLI DSLQDHLEKV KALRGEIAPL KENVNHVNDL AHHLTTLGIQ
     LSPYNLSILE DLNTRWRLLQ VAVEDRVRQL HEAHRDFGPA SQHFLSTSVQ GPWERAISPN
     KVPYYINHET QTTCWDHPKM TELYQSLADL NNVRFSAYRT AMKLRRLQKA LCLDLLSLSA
     ACDALDQHNL KQNDQPMDIL QIINCLTTIY DRLEQEHNNL VNVPLCVDMC LNWLLNVYDT
     GRTGRIRVLS FKTGIISLCK AHLEDKYRYL FKQVASSTGF CDQRRLGLLL HDSIQIPRQL
     GEVASFGGSN IEPSVRSCFQ FANNKPEIEA ALFLDWMRLE PQSMVWLPVL HRVAAAETAK
     HQAKCNICKE CPIIGFRYRS LKHFNYDICQ SCFFSGRVAK GHKMHYPMVE YCTPTTSGED
     VRDFAKVLKN KFRTKRYFAK HPRMGYLPVQ TVLEGDNMET PVTLINFWPV DSAPASSPQL
     SHDDTHSRIE HYASRLAEME NSNGSYLNDS ISPNESIDDE HLLIQHYCQS LNQDSPLSQP
     RSPAQILISL ESEERGELER ILADLEEENR NLQAEYDRLK QQHEHKGLSP LPSPPEMMPT
     SPQSPRDAEL IAEAKLLRQH KGRLEARMQI LEDHNKQLES QLHRLRQLLE QPQAEAKVNG
     TTVSSPSTSL QRSDSSQPML LRVVGSQTSE SMGEEDLLSP PQDTSTGLEE VMEQLNNSFP
     SSRGRNAPGK PMREDTM
//
